No Results Found
You may want to check your spelling and try your search again.
- Try different search terms
- "Car" may return a different set of results than "Cars" or than "Auto"
- Check the spelling of your search terms
- Use more general search terms
You may want to check your spelling and try your search again.
The idea that Botox is a civil rights issue is ludicrous -- and yet that is the line being pushed by Allergan (AGN) in its fight against the 5 percent "Botox tax" proposed in the Senate healthcare reform bill. Instead, Allergan and its rival, Medicis (MRX), should embrace this new tax. Having the federal government dependent on you for revenue will give both companies more clout within the halls of Congress.
Hang onto this essential checklist, so you’ll know what to do when the time comes.